Delcath Systems (DCTH) vs SS Innovations International (SSII)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Delcath Systems (DCTH) has outperformed SS Innovations International (SSII) over the past year, gaining 35.5% versus a loss of 60.9%. SS Innovations International is the larger company by market cap ($526.0 million vs $521.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DCTH | SSII |
|---|---|---|
| Share price | $15.04 | $2.63 |
| Market cap | $521.87M | $526.00M |
| 1-day change | -2.21% | -4.01% |
| YTD return | +48.91% | -53.70% |
| 1-year return | +35.50% | -60.89% |
| 5-year return | +59.83% | — |
| Forward P/E | 334.22 | — |
| EPS (TTM) | $0.01 | $-0.06 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.42 | $10.00 |
| 52-week low | $8.12 | $2.61 |
| Distance from 52-week high | -13.66% | -73.70% |
| Analyst consensus | none | none |
| Avg. price target upside | +59.57% | +166.16% |
| Average volume | 479.73K | 63.49K |
| Shares outstanding | 34.70M | 200.00M |
| Employees | 156 | 483 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- DCTH has outperformed SSII by 96.4 percentage points over the past year.
About Delcath Systems
DCTH stock →Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.
Health Care · Medical/Dental Instruments · 156 employees
About SS Innovations International
SSII stock →SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally. It offers SSi Mantra, a surgical robotic system; and SSi Mudra, a range of stapling, energy, and core instrumentations for surgical systems.
Health Care · Medical/Dental Instruments · 483 employees
DCTH vs SSII FAQ
Which is bigger, Delcath Systems or SS Innovations International?
SS Innovations International (SSII) is larger, with a market capitalization of $526.00M compared with $521.87M for Delcath Systems (DCTH).
Which stock has performed better over the past year, DCTH or SSII?
DCTH returned +35.50% over the past 12 months, compared with -60.89% for SSII (price return, excluding dividends). Past performance does not predict future results.
Are Delcath Systems and SS Innovations International in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.